|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.160 +0.004 (+2.564%) | 2022/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | 2018/06 RMB(K¥) | |
| Turnover | 1,273,572 | 7.459% | 1,185,168 | 1,510,126 | 2,424,416 | 3,968,907 |
| Cost of Sales | (1,069,410) | 4.002% | (1,028,264) | (1,321,626) | (2,097,609) | (3,316,816) |
| Gross Profit | 204,162 | 30.119% | 156,904 | 188,500 | 326,807 | 652,091 |
| 2022/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | 2018/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (3,972) | -- | -- | -- | |
| Change in FV & Impairment on Others | (21,579) | -89.939% | (214,489) | (7,768) | 10,765 | (24,540) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,625) | -- | 3,220 | 10,880 | 6,428 | 1,577 | |
| Profit / (Loss) before Taxation | (188,013) | -71.972% | (670,804) | (492,226) | (263,866) | (963,878) | |
| Taxation | 0 | -- | (5,203) | (1,245) | (3,237) | 39,087 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 366 | -40.098% | 611 | 2,066 | 1,474 | 7,784 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (187,647) | -72.217% | (675,396) | (491,405) | (265,629) | (917,007) | |
| 2022/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | 2018/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (2,322) | -- | 10,615 | (7,388) | (11,275) | (754) |
| Depreciation & Amortisation | 26,055 | -76.079% | 108,920 | 43,648 | 23,752 | 67,642 |
| Directors' Emoluments | 2,675 | 7.819% | 2,481 | 2,330 | 2,711 | 4,030 |
| 2022/06 - Final | %Chg (Compare to Final) | 2021/06 | 2020/06 | 2019/06 | 2018/06 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2022/06 - Final | %Chg (Compare to Final) | 2021/06 | 2020/06 | 2019/06 | 2018/06 | |
| EPS (cts) | -42.660 | -75.599% | -174.830 | -127.450 | -85.800 | -336.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.096) | -- | (0.279) | (1.059) | (0.998) | (0.067) |
| NBV per share ($) | 0.734 | -- | 1.488 | 3.220 | 4.822 | 6.304661 |
| Remarks: | Real time quote last updated: 06/03/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -187,647 |
| %Change | -72.217% |
| EPS / (LPS) | RMB -0.427 |
| NBV Per Share (¥) | RMB 0.734 |